TLDR
- Peptide purity is commonly evaluated using analytical high-performance liquid chromatography, particularly reversed-phase HPLC.
- An HPLC purity percentage usually describes the relative chromatographic peak area detected under a specific set of test conditions.
- HPLC purity does not by itself prove peptide identity.
- A sample reported as 99% HPLC pure is not necessarily 99% peptide by total vial mass.
- Water, counterions, residual solvents, salts, and other components can contribute to material weight without necessarily appearing as peptide-related peaks in a standard HPLC chromatogram.
- Mass spectrometry, amino acid analysis, water determination, counterion analysis, and other methods can answer questions that HPLC alone cannot.
- Strong peptide characterization uses multiple complementary, or orthogonal, analytical methods.
A number such as “99% purity” sounds straightforward.
In peptide chemistry, it is not.
Peptide purity can refer to different analytical measurements, and the meaning of the percentage depends heavily on how it was determined. A chromatographic result, molecular-weight confirmation, peptide-content measurement, water test, and biological assay all provide different information.
Understanding peptide purity therefore starts with a basic question:
Purity measured by what method?
That small question changes how the entire result should be interpreted.
Why Peptide Purity Matters in Research
Synthetic peptides are assembled through a series of chemical reactions.
In solid-phase peptide synthesis, amino acids are typically added sequentially to a growing peptide chain.
Ideally, every coupling and deprotection step proceeds exactly as intended.
In practice, chemical synthesis can generate closely related byproducts.
Potential peptide-related impurities include:
- truncated sequences
- deletion sequences
- insertion sequences
- incompletely deprotected products
- oxidized peptides
- deamidated peptides
- isomerized products
- stereochemical impurities
- modified side chains
- aggregation products
FDA specifically identifies peptide-related impurities arising from insertion, deletion, oxidation, glycosylation, and other changes as important components of peptide impurity profiles.
Solid-phase synthesis can also leave process-related materials such as residual solvents, reagents, catalysts, scavengers, and starting-material-related impurities.
Purification removes much of this material.
Analytical testing then asks how effectively that purification worked.
What Does “Peptide Purity” Actually Mean?
There is no single instrument that produces a complete description of peptide quality.
Several concepts need to be separated.
Chemical or Chromatographic Purity
This usually asks:
How much of the material detected by this analytical method appears to be the desired peptide rather than related impurities?
Reversed-phase HPLC is one of the most common tools for answering this question.
Identity
Identity asks:
Is the material actually the peptide it is supposed to be?
Mass spectrometry is commonly used to help establish molecular identity.
Peptide Content
Peptide content asks a different question:
How much actual peptide is present in a given mass of material?
This can differ from chromatographic purity because lyophilized peptide material may also contain water, counterions, residual solvents, and other substances.
Biological Activity
Activity asks:
Does the peptide perform the expected function in a specified assay?
A chemically pure peptide does not automatically have the expected biological activity.
These four concepts overlap, but they are not interchangeable.
Why HPLC Is Commonly Used to Measure Peptide Purity
High-performance liquid chromatography, or HPLC, separates components of a mixture before measuring them.
Reversed-phase HPLC is particularly common in peptide analysis.
Peptides are loaded onto a chromatographic column containing a relatively hydrophobic stationary phase, often based on C18-bonded silica.
The mobile phase commonly consists of water and an increasing concentration of an organic solvent such as acetonitrile.
Acidic modifiers or ion-pairing agents may also be included to improve peptide separation.
As the solvent conditions change, different molecules interact with the stationary phase to different degrees and leave the column at different times.
The result is a chromatogram.
How to Read a Peptide HPLC Chromatogram
A chromatogram is usually displayed as a graph.
The horizontal axis represents retention time.
The vertical axis represents detector response.
As individual compounds leave the column, the detector records peaks.
For a purified peptide sample, the desired peptide often produces the dominant peak.
Smaller peaks may represent:
- peptide-related impurities
- degradation products
- synthesis byproducts
- other detectable components
If the desired peptide accounts for 99% of the integrated chromatographic signal under the method used, a laboratory might report approximately 99% HPLC purity.
But that number needs context.
What Does 99% HPLC Purity Mean?
Suppose a chromatogram contains one main integrated peak representing 99% of the total detected area and several small peaks totaling 1%.
Under those conditions, the material may be described as 99% pure by HPLC area normalization.
The key phrase is:
by that HPLC method.
The result depends on:
- column chemistry
- mobile phase
- gradient
- temperature
- flow rate
- detection wavelength
- integration settings
- sample preparation
- resolution between peaks
A recent 2026 study examining peptide purification and analysis found that variables such as mobile-phase modifier, flow rate, column characteristics, and gradient conditions can materially affect peptide separation and apparent purity assessment.
So an HPLC purity percentage is not an abstract property of the powder.
It is an analytical result produced by a defined method.
HPLC Separates Molecules Before They Are Detected
A good chromatographic method needs enough resolution to separate the target peptide from relevant impurities.
This is particularly difficult with peptides because many impurities are structurally very similar to the desired product.
Consider a peptide that contains 30 amino acids.
A synthesis impurity missing only one amino acid may have:
- similar size
- similar charge
- similar hydrophobicity
- similar chromatographic behavior
The impurity can therefore elute close to the main peptide.
If two compounds are not adequately separated, their signals can overlap.
This is called co-elution.
A chromatogram may then appear cleaner than the underlying sample actually is.
FDA researchers have demonstrated this issue experimentally. In one study of peptide drug products, conventional HPLC-UV methods failed to adequately resolve certain amino-acid deletion and insertion impurities that were detected using liquid chromatography coupled with high-resolution mass spectrometry.
This is one reason analytical scientists do not assume that one large HPLC peak answers every purity question.
How Peptides Are Detected in HPLC
Separation is only part of HPLC.
Something must detect the compounds as they leave the column.
UV absorbance is commonly used.
Peptide bonds absorb strongly in the far-ultraviolet region, so peptide analysis is often performed around 210 to 220 nm. Detection around 214 nm is especially common.
Aromatic amino acid side chains can also contribute to UV absorption at other wavelengths.
This creates an important limitation.
Different molecules do not necessarily produce identical detector responses for the same amount of material.
Why Peak Area Is Not Always the Same as Mass Percentage
When HPLC peak areas are normalized, the calculation commonly assumes that detector response provides a reasonable estimate of the relative amount of each component.
That can work well under suitable conditions.
But it is not universally exact.
Different peptides can have different UV absorptivities.
Tryptophan, tyrosine, phenylalanine, histidine, methionine, proline, and the number of peptide bonds can all influence absorbance around common peptide detection wavelengths.
Research on peptide quantification has therefore noted that HPLC-UV area normalization can be only semi-quantitative if it assumes equal UV response per unit mass across chemically different components.
In pharmaceutical impurity analysis, relative response factors may be used when important impurities respond differently from the primary analyte.
For routine research material, however, suppliers may simply report area-percent HPLC purity.
That is useful information as long as the reader understands what it represents.
HPLC Purity Does Not Prove Peptide Identity
Imagine a chromatogram containing one beautiful peak accounting for 99.5% of the detected signal.
Does that prove the peak is the peptide listed on the label?
No.
It shows that one major chromatographically detected component dominates the sample.
A different molecule could also produce one major peak.
Establishing identity generally requires additional evidence.
That is where mass spectrometry becomes particularly useful.
What Mass Spectrometry Adds to Peptide Analysis
Mass spectrometry measures ions according to their mass-to-charge ratio.
For peptide characterization, MS can help determine whether the observed molecular mass agrees with the expected peptide.
Electrospray ionization is commonly used for peptides.
Because peptides can carry multiple charges, the instrument may observe several ion peaks representing different charge states of the same molecule.
Software can then reconstruct, or deconvolute, the molecular mass.
If the expected peptide has a theoretical mass and the experimental spectrum agrees closely with that value, the result supports the proposed identity.
But mass confirmation alone is not a full purity analysis.
Two separate questions remain:
Is the main material the expected molecule?
and
What else is present?
HPLC and MS help answer different parts of that problem.
What Is LC-MS?
Liquid chromatography-mass spectrometry, or LC-MS, combines chromatographic separation with mass-spectrometric detection.
The chromatographic system separates sample components.
The mass spectrometer then provides mass information about compounds as they elute.
This makes LC-MS especially useful when investigating closely related peptide impurities.
High-resolution mass spectrometry can distinguish small differences in molecular composition and can help identify:
- deletion sequences
- insertion sequences
- oxidation products
- deamidation products
- truncations
- modified peptides
FDA researchers have used LC-HRMS specifically to improve characterization of impurities that conventional peptide HPLC-UV methods did not adequately resolve.
LC-MS is therefore much more informative than simply looking at a single intact-mass spectrum.
What Does Tandem Mass Spectrometry Add?
Tandem mass spectrometry, or MS/MS, goes beyond measuring intact molecular mass.
A selected peptide ion is fragmented.
The resulting fragment pattern can provide information about the amino acid sequence and the location of modifications.
This is useful because different peptide sequences can occasionally have the same or nearly the same overall molecular mass.
For example, simply confirming intact mass may not reveal every sequence rearrangement or stereochemical difference.
MS/MS provides another level of structural evidence.
Even so, it has limitations.
Certain isomers and stereochemical impurities can remain difficult to distinguish without specialized analytical methods.
HPLC Purity and Peptide Content Are Different
This may be the most important distinction in peptide quality reporting.
Suppose a laboratory weighs 10 milligrams of a lyophilized peptide preparation.
That 10 milligrams does not necessarily consist entirely of peptide molecules.
The material may also contain:
- water
- acetate
- trifluoroacetate
- other counterions
- residual solvent
- inorganic residue
- other non-peptide components
Some of these components are expected consequences of synthesis, purification, salt form, or lyophilization.
They do not necessarily appear as ordinary peptide-related peaks in a standard reversed-phase HPLC chromatogram.
The United States Pharmacopeia has published peptide reference-standard work that explicitly separates HPLC-detected impurities from counterions and other weight-based contributions when assigning peptide purity and content.
That means:
99% HPLC purity does not automatically mean 0.99 mg of peptide per 1.00 mg of lyophilized powder.
A Simple Example
Consider a hypothetical vial containing 100 mg of dry-looking material.
Suppose analytical HPLC reports:
99% HPLC area purity
But further testing shows that some of the sample mass consists of:
- bound water
- an acetate counterion
- trace residual solvent
The chromatogram may still report approximately 99% peptide-related purity because those components are not being quantified in the same way as peptide peaks.
The actual mass of peptide free base per 100 mg of material could therefore be lower than 99 mg.
This does not automatically mean the HPLC result is wrong.
It means the HPLC test and peptide-content test are measuring different things.
Why Peptides Have Counterions
Peptides frequently contain ionizable functional groups.
During synthesis and purification, they may be isolated as salts.
Common counterions can include:
- acetate
- trifluoroacetate
- hydrochloride-associated chloride
The exact salt form depends on the process.
Counterions contribute mass to the final material.
A peptide may therefore be highly pure chemically while its total preparation contains a meaningful percentage of counterion by weight.
Counterion identity and concentration can be measured separately using techniques such as ion chromatography or other validated analytical methods.
This is another reason “purity” should not be used as a synonym for “peptide content.”
How Water Content Is Measured
Lyophilized material can retain water or absorb moisture from the environment.
Water does not necessarily produce a standard peptide HPLC peak.
It still contributes to total sample mass.
One common analytical approach is Karl Fischer titration, which is specifically designed to quantify water.
For carefully characterized peptide reference standards, water content can be used to convert results between an anhydrous basis and an “as-is” basis. USP-authored work on synthetic peptide reference standards describes this type of correction explicitly.
Moisture therefore matters when accurate peptide quantity is required.
Amino Acid Analysis Can Help Determine Peptide Quantity
Amino acid analysis, or AAA, provides another approach to peptide characterization and quantification.
The peptide is hydrolyzed into its constituent amino acids.
Those amino acids are then separated and quantitatively measured.
If the expected sequence is known, the resulting amino acid composition can be compared with the theoretical composition.
AAA can provide accurate information about peptide quantity and composition.
A 2024 methods publication describes amino acid analysis as an accurate approach for composition and quantitation of polypeptides and synthetic peptides, particularly when combined with mass spectrometry.
The method has limitations.
For example, some amino acids can be destroyed or chemically changed during hydrolysis.
Tryptophan can be lost under common acid-hydrolysis conditions, while asparagine and glutamine are converted to their corresponding acidic forms.
So even a strong analytical technique has to be interpreted according to its chemistry.
Other Methods Used to Characterize Peptide Quality
Depending on the peptide and research purpose, laboratories may use additional techniques.
Nuclear Magnetic Resonance
NMR can provide structural and quantitative information.
It may be useful for confirming molecular features or assigning content in well-characterized reference materials.
Size-Exclusion Chromatography
SEC separates molecules mainly according to their hydrodynamic size.
It can be useful for investigating peptide or protein aggregation and higher-molecular-weight species.
Ion-Exchange Chromatography
Ion-exchange chromatography separates molecules according to charge-related interactions.
It can resolve variants that may not separate well by reversed-phase chromatography.
Capillary Electrophoresis
Capillary electrophoresis separates molecules according to electrophoretic mobility and provides another orthogonal method for some peptide systems.
Chiral Analysis
Stereochemistry matters because natural proteinogenic amino acids normally have defined configurations.
Racemization can occur during peptide synthesis.
Specialized chiral chromatography or other analytical strategies may therefore be needed to detect D-amino-acid-containing impurities. A 2024 review highlighted enantiomeric purity as a distinct analytical challenge for synthetic therapeutic peptides.
No single one of these methods replaces every other method.
They answer different questions.
What Does “Orthogonal Analysis” Mean?
Analytical scientists often use the word orthogonal to describe methods that examine a sample using different physical or chemical principles.
For example:
HPLC-UV separates and detects chromatographic components.
Mass spectrometry examines molecular mass.
Amino acid analysis measures amino acid composition and quantity.
Karl Fischer analysis measures water.
Ion chromatography can measure counterions.
Using these together produces a much more complete characterization than repeating the same test several times.
This principle is central to pharmaceutical characterization, where identity, purity, impurities, quantity, potency, and other quality attributes are treated as separate analytical questions.
Why Closely Related Peptide Impurities Can Be Hard to Detect
Peptide synthesis has an unusual analytical problem.
Many impurities are almost the same molecule as the desired peptide.
Consider an oxidation product.
The peptide sequence may remain essentially the same, while only one residue has undergone a chemical modification.
Or consider a deletion impurity.
The entire sequence may be correct except for one missing amino acid.
These compounds can have very similar:
- molecular weights
- hydrophobicity
- charge
- chromatographic retention
- UV response
That similarity makes peptide impurity analysis more challenging than simply separating completely unrelated molecules.
Modern pharmaceutical analysis increasingly combines high-resolution separations with mass spectrometry and other methods for precisely this reason.
Purification and Purity Testing Are Not the Same Thing
Another common source of confusion is the difference between preparative HPLC and analytical HPLC.
Preparative chromatography is used to collect purified material.
Its goal is production.
Analytical chromatography uses a much smaller sample to measure composition.
Its goal is analysis.
A peptide may therefore be:
- synthesized;
- purified using preparative chromatography;
- collected and lyophilized;
- tested again using an analytical chromatographic method.
The analytical test evaluates the result of the purification process.
The two processes may use related chemistry, but they serve different purposes.
What Should a Peptide Certificate of Analysis Show?
A certificate of analysis, or COA, is only useful when the reader understands what was tested.
At minimum, a scientifically useful peptide COA should clearly identify the material and state the methods used for the reported results.
Depending on the purpose of the material, useful information may include:
- peptide name
- amino acid sequence
- theoretical molecular mass
- observed molecular mass
- chromatographic purity
- analytical method
- lot or batch identifier
- counterion or salt form
- relevant storage information
More extensively characterized materials may also include:
- water content
- peptide content
- residual solvent analysis
- amino acid analysis
- counterion determination
- aggregate testing
- biological activity data
Not every research peptide requires every test.
But a bare statement such as “99% pure” leaves an important question unanswered.
99% by what method?
Purity Is Not the Same as Sterility
This distinction is also important.
Chemical purity testing does not determine whether a material is sterile.
HPLC does not establish:
- sterility
- endotoxin level
- microbial contamination
- particulate contamination
Those require separate tests.
Likewise, a sterile material is not necessarily chemically pure.
These are independent quality attributes.
Purity Is Not the Same as Biological Potency
A sample can also pass chemical identity and purity testing without necessarily having the expected activity in a biological system.
Biological activity can depend on factors such as:
- correct sequence
- conformation
- aggregation
- oxidation
- target interaction
- experimental conditions
For some peptide products, regulators therefore consider biological activity and higher-order structure in addition to conventional chemical impurity testing.
In July 2026, FDA published revised product-specific guidance for 17 generic peptide products. The updated recommendations include impurity thresholds, higher-order structure assessment, biological activity, and other peptide-specific considerations.
That provides a useful real-world example of why peptide quality cannot be reduced to one HPLC percentage.
How Researchers Should Interpret a Purity Claim
A useful way to read peptide analytical data is to ask a series of separate questions.
1. Is the sequence supposed to be correct?
Start with the stated sequence.
2. Was molecular identity tested?
Look for mass spectrometry or another appropriate identity method.
3. How was chromatographic purity measured?
Look for the type of chromatography and, ideally, the detection method.
4. Does the chromatographic method resolve relevant impurities?
A large main peak is meaningful only if the method can separate important related compounds.
5. Is actual peptide content known?
Do not automatically convert HPLC area purity into milligrams of peptide per milligram of powder.
6. Were water and counterions measured?
These can materially affect total mass.
7. Is biological activity relevant to the experiment?
If so, chemical characterization may need to be paired with a functional assay.
Thinking this way avoids placing too much weight on one attractive percentage.
There Is No Single “Purity Machine”
Peptide characterization works best as a collection of measurements.
HPLC is valuable because it shows chromatographic heterogeneity.
Mass spectrometry provides molecular-mass and structural information.
LC-MS combines separation and mass detection.
Amino acid analysis can provide quantitative composition information.
Additional tests can measure water, solvents, counterions, stereochemical purity, aggregation, and biological activity.
Together, those measurements provide a much stronger picture of peptide quality.
So when a peptide is described as “99% pure,” the scientifically useful response is not simply to accept or reject the number.
It is to ask what the number actually measures.
That is the difference between reading a purity claim and understanding one.
FAQs
How Is Peptide Purity Usually Measured?
Analytical reversed-phase HPLC with UV detection is one of the most common methods. The percentage often represents the relative integrated peak area of the desired peptide compared with other detected chromatographic peaks.
Does 99% HPLC Purity Mean 99% of the Powder Is Peptide?
Not necessarily. Water, counterions, residual solvents, salts, and other components can contribute to total material mass without being included in a standard HPLC area-purity value.
Can HPLC Confirm Which Peptide Is Present?
HPLC retention behavior can support identification when compared with appropriate standards, but HPLC purity alone does not establish molecular identity. Mass spectrometry is commonly used as an additional identity test.
What Is the Difference Between HPLC and LC-MS?
HPLC separates sample components. LC-MS couples chromatographic separation with mass-spectrometric detection, providing molecular-mass information about compounds as they elute.
Why Can Two Laboratories Report Different HPLC Purity Values?
Different columns, gradients, mobile phases, temperatures, detector settings, integration procedures, and method resolution can affect chromatographic results. The analytical method matters.
What Is Peptide Content?
Peptide content describes the amount of actual peptide present within a given quantity of material. It is different from chromatographic area purity.
Is HPLC Alone Enough to Fully Characterize a Peptide?
Usually not when comprehensive characterization is required. Identity, chromatographic purity, content, water, counterions, stereochemistry, aggregation, and activity can require different analytical methods.
Does High Purity Prove a Peptide Is Biologically Active?
No. Chemical purity and biological activity are separate measurements.
References
- U.S. Food and Drug Administration. Guidance for Industry: Synthetic Peptides. FDA guidance concerning peptide-related and process-related impurities.
- U.S. Food and Drug Administration. Likely Impurities in Synthetic Peptides. Discussion of SPPS-related impurities, truncations, side reactions, residual reagents, and related materials.
- Sharma N, Kukreja D, Giri T, Kumar S, Shah RP. Synthetic pharmaceutical peptides characterization by chromatography principles and method development. Journal of Separation Science. 2022;45:2200-2216.
- Streuli A, Erckes V, Nardone B, et al. Improvement of Analysis and Transferability in Peptide Purification: From HPLC to FPLC and Back Again. Journal of Peptide Science. 2026;32:e70090.
- Yang Y, et al. Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control. AAPS Journal.
- Williams RL, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharmaceutical Research. 2023;40:1317-1328.
- Højrup P. Analysis of Peptides and Conjugates by Amino Acid Analysis. Methods in Molecular Biology. 2015.
- Analysis of Polypeptides by Amino Acid Analysis. Methods in Molecular Biology. 2024.
- Kuipers BJH, Gruppen H. Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm. Journal of Agricultural and Food Chemistry.
- Badgujar D, Paritala ST, Matre S, Sharma N. Enantiomeric purity of synthetic therapeutic peptides: A review. Chirality. 2024;36(3).
- ICH. Q6B: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products.
- U.S. Food and Drug Administration. FDA Publishes Revised Draft Product-Specific Guidances for Certain Generic Peptide Products. July 28, 2026.